A study says that a molecular switch that flips between different versions of genes could be crucial for maintaining stem cells across all animals from simple flatworms to humans.
The study at Center for Genomic Regulation says that flatworms (also known as planarians) have an incredible capacity for self-renewal, with almost any part of their body able to regenerate a whole new worm in a matter of days.
The researchers found that they 'mix and match' certain parts of their genes in particular ways - a process known as alternative splicing. The same analysis of flatworm cells that had changed into more specific cell types revealed a different mixture of gene parts.
Looking more closely, the team discovered that two families of molecules - CELF and MBNL - work as a kind of 'yin and yang' switch, enabling cells to flip between different patterns of alternative splicing. CELF molecules guide gene splicing patterns linked to self-renewal of stem cells, while MBNL factors favour differentiation.
The study builds on Irimia's previous research showing that MBNL proteins and alternative splicing patterns are important in human and mouse embryonic stem cells as they differentiate into other cell types.
Previously, scientists have discovered certain proteins, known as transcription factors that are important for maintaining embryonic stem cells in mammals.
However, these particular molecules do not play the same roles in the stem cells of invertebrate organisms such as flatworms, which split off from the ancestors of mammals around 600 million years ago, suggesting that they are quite new in evolutionary terms.
"Discovering that this kind of alternative splicing mechanism exists across such a wide evolutionary range suggests that it is very ancient, and may be equally important as transcription factors for giving animal stem cells their unique properties" said lead researcher Manuel Irimia.
"Furthermore, understanding how this 'yin and yang' switch is flipped and activates particular patterns of alternative splicing could one day lead to more improved methods for generating and differentiating stem cells, which could be used be used for regenerative medicine," Irimia added.
The study has been published in eLife.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
